Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts - PubMed
. 1999 Jan;31(1):297-303.
doi: 10.1006/jmcc.1998.0864.
Affiliations
- PMID: 10072736
- DOI: 10.1006/jmcc.1998.0864
Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts
I L Grupp et al. J Mol Cell Cardiol. 1999 Jan.
Abstract
Peroxynitrite and hydroxyl radical are reactive oxidants produced during myocardial reperfusion injury. They have been shown to induce dysfunction in cardiac myocytes, in part, via the activation of the nuclear enzyme poly (ADP-ribose) synthetase (PARS). These oxidants can trigger DNA single strand breakage, which triggers PARS activation, resulting in cellular NAD+ and ATP depletion and cytotoxicity. Recent work has demonstrated that hypoxia-reoxygenation of cardiac myocytes in vitro also causes peroxynitrite formation, PARS activation and cytotoxicity. In the present study, using hearts from genetically engineered mice lacking PARS, we have investigated whether the absence of PARS alters the functional response to hypoxia reoxygenation. Isolated work-performing mouse hearts were stabilized under the same loading condition (cardiac minute work of 250 mmHg x ml/min, an afterload of 50 mmHg aortic pressure and similar venous return of 5 ml/min, resulting in the same preload). After 30 min equilibration the hearts were subjected to 30 min hypoxia followed by 30 min of reoxygenation. At the end of the reoxygenation, in hearts from wild-type animals, there was a significant suppression in the rate of intraventricular pressure development (+dP/dt) from 3523 to 2907 mmHg. There was also a significant suppression in the rate of relaxation (-dP/dt) in the wild-type hearts from 3123 to 2168 mmHg. The time to peak pressure (TPP) increased from 0.48 to 0.59 ms/mmHg and the half-time of relaxation (RT1/2) increased from 0.59 to 0.74 ms/mmHg. In contrast, in the hearts from the PARS knockout animals, no significant suppression of +dP/dt (from 3654 to 3419 mmHg), and no significant increase in the TPP (from 0.462 to 0.448 ms/mmHg) were found, and the decrease in -dP/dt was partially ameliorated (from 3399 to 2687 mmHg) as well as the half-time of relaxation (from 0.507 to 0.55 ms/mmHg) when compared to the response to the wild-type hearts. The current data demonstrate that the reoxygenation induced suppression of the myocardial contractility is dependent on the functional integrity of PARS.
Similar articles
-
Gilad E, Zingarelli B, Salzman AL, Szabó C. Gilad E, et al. J Mol Cell Cardiol. 1997 Sep;29(9):2585-97. doi: 10.1006/jmcc.1997.0496. J Mol Cell Cardiol. 1997. PMID: 9299380
-
Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C. Cuzzocrea S, et al. Br J Pharmacol. 1997 Jul;121(6):1065-74. doi: 10.1038/sj.bjp.0701234. Br J Pharmacol. 1997. PMID: 9249240 Free PMC article.
-
Zingarelli B, Cuzzocrea S, Zsengellér Z, Salzman AL, Szabó C. Zingarelli B, et al. Cardiovasc Res. 1997 Nov;36(2):205-15. doi: 10.1016/s0008-6363(97)00137-5. Cardiovasc Res. 1997. PMID: 9463632
-
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Liaudet L, Yang Z, Al-Affar EB, Szabó C. Liaudet L, et al. Mol Med. 2001 Jun;7(6):406-17. Mol Med. 2001. PMID: 11474134 Free PMC article.
-
Role of poly(ADP-ribose)synthetase in inflammation.
Szabó C. Szabó C. Eur J Pharmacol. 1998 May 29;350(1):1-19. doi: 10.1016/s0014-2999(98)00249-0. Eur J Pharmacol. 1998. PMID: 9683009 Review.
Cited by
-
Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?
Morales P, Bustamante D, Espina-Marchant P, Neira-Peña T, Gutiérrez-Hernández MA, Allende-Castro C, Rojas-Mancilla E. Morales P, et al. EPMA J. 2011 Jun;2(2):211-30. doi: 10.1007/s13167-011-0100-3. Epub 2011 Jul 26. EPMA J. 2011. PMID: 23199150 Free PMC article.
-
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.
Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Del Re DP, et al. Physiol Rev. 2019 Oct 1;99(4):1765-1817. doi: 10.1152/physrev.00022.2018. Physiol Rev. 2019. PMID: 31364924 Free PMC article. Review.
-
del Moral RM, Gómez-Morales M, Hernández-Cortés P, Aguilar D, Caballero T, Aneiros-Fernández J, Caba-Molina M, Rodríguez-Martínez MD, Peralta A, Galindo-Moreno P, Osuna A, Oliver FJ, del Moral RG, O'Valle F. del Moral RM, et al. ScientificWorldJournal. 2013 Nov 11;2013:486574. doi: 10.1155/2013/486574. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24319370 Free PMC article.
-
McDonald MC, Filipe HM, Thiemermann C. McDonald MC, et al. Br J Pharmacol. 1999 Nov;128(6):1339-45. doi: 10.1038/sj.bjp.0702928. Br J Pharmacol. 1999. PMID: 10578150 Free PMC article.
-
Xu W, Li L, Zhang L. Xu W, et al. Front Physiol. 2020 Aug 13;11:901. doi: 10.3389/fphys.2020.00901. eCollection 2020. Front Physiol. 2020. PMID: 32903597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous